National Presto shifts sourcing to place new products outside China; names new VP Engineering; unveils new product lines

NATIONAL PRESTO INDUSTRIES INC

Sourcing strategy changed: will place new Housewares/Small Electric products outside China rather than moving all existing products from China.
Shane Straw, Sr. appointed VP of Engineering; previously Housewares/Small Appliance segment Director of Engineering since July 2025.
Safety segment launched ten Rely FX fire extinguishers (4-20 lbs), including first UL-listed fluorine-free foam unit; submitted for Mil-Spec approval.
Housewares segment introduced 16- and 23-quart digital pressure canners, 30-quart boiling water canner, and restyled HeatDish Plus heater.

item 5.03 item 5.07 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-26-018109
form_type: 8-K
ticker: NPK
cik: 0000080172
company_name: NATIONAL PRESTO INDUSTRIES INC
filed_at: 2026-05-21T20:34:07+00:00
discovered_at: 2026-05-21T20:35:00.516011+00:00
generated_at: 2026-05-21T20:37:11.448681+00:00
sec_items: ["5.03", "5.07", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-26-018109
json_url: https://secwatch.observer/filing/0001437749-26-018109.json
markdown_url: https://secwatch.observer/filing/0001437749-26-018109.md
text_url: https://secwatch.observer/filing/0001437749-26-018109.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/80172/000143774926018109/0001437749-26-018109-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/80172/000143774926018109/npk20260521_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 5.03, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DCOM

Dime Commercial Bancshares name change effective; three executives amend employment agreements

Dime Community Bancshares, Inc. /NY/ June 1, 2026, 4:02 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 5.03, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same SEC item: 5.03, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

XAIR

Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026

Beyond Air, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTOR

Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer

CITIUS ONCOLOGY, INC. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001437749-26-018109

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.